The Frequency of Intestinal Parasitic Infections in COVID-19 Patients: A Case-Control Study in Tehran, Capital of Iran

The present study was done to evaluate the prevalence of intestinal parasitic infections (IPIs) in patients with COVID-19 in health care centers (Imam Reza and Golestan hospitals), Tehran, capital of Iran. By designing a matched case-control study, 200 fecal samples were collected for each of the CO...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali Taghipour, Majid Pirestani, Ramin Hamidi Farahani, Mohammad Barati
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of Tropical Medicine
Online Access:http://dx.doi.org/10.1155/2023/5359823
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547877612683264
author Ali Taghipour
Majid Pirestani
Ramin Hamidi Farahani
Mohammad Barati
author_facet Ali Taghipour
Majid Pirestani
Ramin Hamidi Farahani
Mohammad Barati
author_sort Ali Taghipour
collection DOAJ
description The present study was done to evaluate the prevalence of intestinal parasitic infections (IPIs) in patients with COVID-19 in health care centers (Imam Reza and Golestan hospitals), Tehran, capital of Iran. By designing a matched case-control study, 200 fecal samples were collected for each of the COVID-19 patients and healthy individuals. Nasopharyngeal/oropharyngeal swab samples were collected from all participants for the diagnosis of COVID-19. RNA extraction was performed, and then real time reverse-transcription polymerase chain reaction (rRT-PCR) assay was applied to detect viral RNA. Considering the lung complications, 25%> lung complications was detected in 49 patients, 25–49% in 42 patients, and 50%≤ in 109 patients. Fecal samples were examined using different parasitological techniques. After nested-PCR, sequencing was applied to identify Cryptosporidium spp. and microsporidia spp. A relatively lower prevalence of IPIs was detected among control group (7.5%), than in COVID-19 patients (13%), though not significant P=0.13. The most prevalent parasite among patients was Blastocystis sp. (6%). Also, 13.76% of IPIs were detected in inpatients with more than 50% lung complication. As well, a remarkably significant difference in IPIs was observed among diarrheic COVID-19 patients, in comparison with nondiarrheic patients P<0.00001. Moreover, the isolated sequences in the present study belonged to C. parvum subtype IIa and Enterocytozoon bieneusi genotypes D and Peru 8. In conclusion, more epidemiological and clinical research studies are needed to better understand the status and interaction of IPI in COVID-19 in Iran and other countries.
format Article
id doaj-art-d2f5af7a27864ed99065821226aae88a
institution Kabale University
issn 1687-9694
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Journal of Tropical Medicine
spelling doaj-art-d2f5af7a27864ed99065821226aae88a2025-02-03T06:43:09ZengWileyJournal of Tropical Medicine1687-96942023-01-01202310.1155/2023/5359823The Frequency of Intestinal Parasitic Infections in COVID-19 Patients: A Case-Control Study in Tehran, Capital of IranAli Taghipour0Majid Pirestani1Ramin Hamidi Farahani2Mohammad Barati3Zoonoses Research CenterDepartment of ParasitologyInfectious Diseases Research CenterInfectious Diseases Research CenterThe present study was done to evaluate the prevalence of intestinal parasitic infections (IPIs) in patients with COVID-19 in health care centers (Imam Reza and Golestan hospitals), Tehran, capital of Iran. By designing a matched case-control study, 200 fecal samples were collected for each of the COVID-19 patients and healthy individuals. Nasopharyngeal/oropharyngeal swab samples were collected from all participants for the diagnosis of COVID-19. RNA extraction was performed, and then real time reverse-transcription polymerase chain reaction (rRT-PCR) assay was applied to detect viral RNA. Considering the lung complications, 25%> lung complications was detected in 49 patients, 25–49% in 42 patients, and 50%≤ in 109 patients. Fecal samples were examined using different parasitological techniques. After nested-PCR, sequencing was applied to identify Cryptosporidium spp. and microsporidia spp. A relatively lower prevalence of IPIs was detected among control group (7.5%), than in COVID-19 patients (13%), though not significant P=0.13. The most prevalent parasite among patients was Blastocystis sp. (6%). Also, 13.76% of IPIs were detected in inpatients with more than 50% lung complication. As well, a remarkably significant difference in IPIs was observed among diarrheic COVID-19 patients, in comparison with nondiarrheic patients P<0.00001. Moreover, the isolated sequences in the present study belonged to C. parvum subtype IIa and Enterocytozoon bieneusi genotypes D and Peru 8. In conclusion, more epidemiological and clinical research studies are needed to better understand the status and interaction of IPI in COVID-19 in Iran and other countries.http://dx.doi.org/10.1155/2023/5359823
spellingShingle Ali Taghipour
Majid Pirestani
Ramin Hamidi Farahani
Mohammad Barati
The Frequency of Intestinal Parasitic Infections in COVID-19 Patients: A Case-Control Study in Tehran, Capital of Iran
Journal of Tropical Medicine
title The Frequency of Intestinal Parasitic Infections in COVID-19 Patients: A Case-Control Study in Tehran, Capital of Iran
title_full The Frequency of Intestinal Parasitic Infections in COVID-19 Patients: A Case-Control Study in Tehran, Capital of Iran
title_fullStr The Frequency of Intestinal Parasitic Infections in COVID-19 Patients: A Case-Control Study in Tehran, Capital of Iran
title_full_unstemmed The Frequency of Intestinal Parasitic Infections in COVID-19 Patients: A Case-Control Study in Tehran, Capital of Iran
title_short The Frequency of Intestinal Parasitic Infections in COVID-19 Patients: A Case-Control Study in Tehran, Capital of Iran
title_sort frequency of intestinal parasitic infections in covid 19 patients a case control study in tehran capital of iran
url http://dx.doi.org/10.1155/2023/5359823
work_keys_str_mv AT alitaghipour thefrequencyofintestinalparasiticinfectionsincovid19patientsacasecontrolstudyintehrancapitalofiran
AT majidpirestani thefrequencyofintestinalparasiticinfectionsincovid19patientsacasecontrolstudyintehrancapitalofiran
AT raminhamidifarahani thefrequencyofintestinalparasiticinfectionsincovid19patientsacasecontrolstudyintehrancapitalofiran
AT mohammadbarati thefrequencyofintestinalparasiticinfectionsincovid19patientsacasecontrolstudyintehrancapitalofiran
AT alitaghipour frequencyofintestinalparasiticinfectionsincovid19patientsacasecontrolstudyintehrancapitalofiran
AT majidpirestani frequencyofintestinalparasiticinfectionsincovid19patientsacasecontrolstudyintehrancapitalofiran
AT raminhamidifarahani frequencyofintestinalparasiticinfectionsincovid19patientsacasecontrolstudyintehrancapitalofiran
AT mohammadbarati frequencyofintestinalparasiticinfectionsincovid19patientsacasecontrolstudyintehrancapitalofiran